21 CFR 820.30: Design controls
Required manufacturers of class II and III devices, and certain class I devices, to establish procedures controlling device design, including planning, input, output, review, verification, validation, and documentation in a design history file.
Part 820, Quality System Regulation · Subpart C, Design Controls
Most device 483s cite the Quality System Regulation in force before February 2, 2026, when the QMSR replaced it. Those sections are marked Former.
How FDA words it
The opening lines investigators use most when they cite 820.30, from the 483s we hold.
Procedures for design change have not been adequately established.Most used
Procedures for design control have not been established.820.30(a)
Procedures for design validation have not been adequately established.820.30(g)
Cited over time
483s citing 820.30, by yearMost citations in 2019. Bars are relative to the busiest year. *2026 to date.
Years shown: 2017 to 2026. The busiest year was 2019.
Recent 483s citing 820.30
- Seniorlife Technologies Inc · Bellevue, WashingtonDesign and development procedures were not documented… Feb 20, 2026
- SpineSmith Holdings, LLC · Austin, TexasIn product realization planning your firm did not adequately determine, as… Feb 13, 2026
- Amigo Mobility International, Inc. · —One or more processes for risk management in product realization have not been… Feb 5, 2026
- Expanse Medical Inc. · Pleasanton, CaliforniaProcedures for design validation have not been adequately established… Jan 15, 2026
- Nuclein LLC · Austin, TexasRisk analysis is inadequate… Jan 13, 2026
The regulation text
§ 820.30 Design controls. As published before it was replaced.
(a)General. (1) Each manufacturer of any class III or class II device, and the class I devices listed in paragraph (a)(2) of this section, shall establish and maintain procedures to control the design of the device in order to ensure that specified design requirements are met.
(2)The following class I devices are subject to design controls:
(i)Devices automated with computer software; and
(ii)The devices listed in the following chart.
Section
Device
868.6810
Catheter, Tracheobronchial Suction.
878.4460
Glove, Surgeon's.
880.6760
Restraint, Protective.
892.5650
System, Applicator, Radionuclide, Manual.
892.5740
Source, Radionuclide Teletherapy.
(b)Design and development planning. Each manufacturer shall establish and maintain plans that describe or reference the design and development activities and define responsibility for implementation. The plans shall identify and describe the interfaces with different groups or activities that provide, or result in, input to the design and development process. The plans shall be reviewed, updated, and approved as design and development evolves.
(c)Design input. Each manufacturer shall establish and maintain procedures to ensure that the design requirements relating to a device are appropriate and address the intended use of the device, including the needs of the user and patient. The procedures shall include a mechanism for addressing incomplete, ambiguous, or conflicting requirements. The design input requirements shall be documented and shall be reviewed and approved by a designated individual(s). The approval, including the date and signature of the individual(s) approving the requirements, shall be documented.
(d)Design output. Each manufacturer shall establish and maintain procedures for defining and documenting design output in terms that allow an adequate evaluation of conformance to design input requirements. Design output procedures shall contain or make reference to acceptance criteria and shall ensure that those design outputs that are essential for the proper functioning of the device are identified. Design output shall be documented, reviewed, and approved before release. The approval, including the date and signature of the individual(s) approving the output, shall be documented.
(e)Design review. Each manufacturer shall establish and maintain procedures to ensure that formal documented reviews of the design results are planned and conducted at appropriate stages of the device's design development. The procedures shall ensure that participants at each design review include representatives of all functions concerned with the design stage being reviewed and an individual(s) who does not have direct responsibility for the design stage being reviewed, as well as any specialists needed. The results of a design review, including identification of the design, the date, and the individual(s) performing the review, shall be documented in the design history file (the DHF).
(f)Design verification. Each manufacturer shall establish and maintain procedures for verifying the device design. Design verification shall confirm that the design output meets the design input requirements. The results of the design verification, including identification of the design, method(s), the date, and the individual(s) performing the verification, shall be documented in the DHF.
(g)Design validation. Each manufacturer shall establish and maintain procedures for validating the device design. Design validation shall be performed under defined operating conditions on initial production units, lots, or batches, or their equivalents. Design validation shall ensure that devices conform to defined user needs and intended uses and shall include testing of production units under actual or simulated use conditions. Design validation shall include software validation and risk analysis, where appropriate. The results of the design validation, including identification of the design, method(s), the date, and the individual(s) performing the validation, shall be documented in the DHF.
(h)Design transfer. Each manufacturer shall establish and maintain procedures to ensure that the device design is correctly translated into production specifications.
(i)Design changes. Each manufacturer shall establish and maintain procedures for the identification, documentation, validation or where appropriate verification, review, and approval of design changes before their implementation.
(j)Design history file. Each manufacturer shall establish and maintain a DHF for each type of device. The DHF shall contain or reference the records necessary to demonstrate that the design was developed in accordance with the approved design plan and the requirements of this part.
Questions
What does 21 CFR 820.30 require?
Required manufacturers of class II and III devices, and certain class I devices, to establish procedures controlling device design, including planning, input, output, review, verification, validation, and documentation in a design history file.
How do FDA investigators word a 820.30 observation?
The most common opening is: “Procedures for design change have not been adequately established.”
Which sections are cited alongside 820.30?
In the same 483s, investigators most often also cite 820.100 (Corrective and preventive action), 820.198 (Complaint files), 820.50 (Purchasing controls), 820.75 (Process validation).